Integra LifeSciences | IART - Cost Of Sales


Integra LifeSciences reported $186.73M in Cost of Sales for its fiscal quarter ending in September of 2026.





Cost Of Sales Change Date
Abbott USD 6.47B 525M Sep/2026
AtriCure USD 35.1M 125K Sep/2026
Baxter International USD 1.98B 54M Sep/2026
Becton, Dickinson and Co. USD 2.58B 87M Sep/2026
Boston Scientific USD 1.96B 93M Sep/2026
CONMED USD 146.41M 379K Sep/2026
Cooper Companies USD 401.3M 7.5M Jun/2026
Dexcom USD 478.4M 36.8M Jun/2026
Edwards Lifesciences USD 369.2M 23.2M Sep/2026
Globus Medical USD 262.49M 8.51M Sep/2026
Insulet USD 209.9M 29.2M Sep/2026
Integra LifeSciences USD 186.73M 2.13M Sep/2026
Intuitive Surgical USD 964.4M 32.5M Sep/2026
J&J USD 8.08B 80M Sep/2026
Medtronic USD 3.83B 26M Jun/2026
Merit Medical Systems USD 203.68M 6.6M Jun/2026
Orthofix International USD 66.63M 6.4M Dec/2025
Smith & Nephew USD 901M 31M Jun/2026
Stryker USD 2.26B 106M Jun/2026
Tandem Diabetes Care USD 123.27M 13.49M Sep/2026
Teleflex USD 199M 39.63M Sep/2026
Zimmer Biomet Holdings USD 760.5M 55.4M Sep/2026